Target intelligence / Profile preview

Proteasome activator subunit 2 pseudogene 2 (PSME2P2)

Target
PSME2P2
Molecular classification
Other (Pseudogene)
01

Overview

Proteasome activator subunit 2 pseudogene 2 (PSME2P2) is a processed pseudogene of the human *PSME2* gene, which encodes the beta subunit of the PA28 (11S) proteasome activator complex. While the functional *PSME2* gene product plays a role in immunoproteasome assembly and antigen processing, PSME2P2 lacks the capacity to code for a functional protein due to mutations or sequence truncation. Like other pseudogenes, it may have minor regulatory RNA roles, but is not considered a direct molecular target for drug discovery, receptor research, or therapeutic intervention. Clarification of Issues: - PSME2P2 is a **pseudogene**, not a functional gene or protein, and does not serve as a receptor, enzyme, or drug target in any established context. - Information about protein structure, function, and druggability refers to the *parent gene* (*PSME2*), not to the pseudogene PSME2P2 itself. - If the intent was to find information for the canonical, functional protein, refer to "Proteasome activator subunit 2 (PA28 beta)" (PSME2), *not* to PSME2P2. Summary: PSME2P2 is a non-functional DNA sequence derived from a duplication or retrotransposition of the protein-coding *PSME2* gene. It has no established therapeutic, diagnostic, or pharmacological relevance, and should not be considered a canonical drug target.

Other names
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) pseudogenePSME2 pseudogene 2PA28 beta pseudogene 2

Beyond the preview

Go deeper on Proteasome activator subunit 2 pseudogene 2 (PSME2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome activator subunit 2 pseudogene 2 (PSME2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call